Upsher-Smith Announces New Formulation of PreNexa(R) Prenatal Vitamins

MAPLE GROVE, Minn., Feb. 2 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. is pleased to announce the introduction of a new formulation of PreNexa® Rx prenatal vitamins.  The new formulation contains an increased amount of algal-oil, plant-based docosahexaenoic acid (DHA), from 265 mg to 300 mg and increased vitamin D3, from 170 IU to 400 IU.(1)

DHA, a key omega-3 fatty acid used throughout the body, helps support fetal and infant brain and eye development.(2,3) Vitamin D is an essential vitamin for mom's and baby's skeletal health.(4)

"PreNexa® is the fastest growing single-capsule prenatal vitamin with plant-based DHA on the market.  This new formulation reflects the increasing body of evidence pointing to the important role DHA and vitamin D play in pregnancy, lactation and infancy," said Wesley Mark Todd, MD, Senior Director Medical Affairs, Upsher-Smith Laboratories, Inc.  

The NDC number for the new formulation of PreNexa® is 0245-0177-30.  Key product features remain the same, including: the bottle configuration, amount per bottle (30 gel capsules), look of the gel capsule, and regimen of one pill once daily.  

Important Safety Information

Please see full Prescribing Information for a complete list of warnings and precautions. Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six.  KEEP THIS PRODUCT OUT OF REACH OF CHILDREN.  In case of accidental overdose, call a doctor or poison control center immediately.

About Upsher-Smith

Upsher-Smith Laboratories, Inc. is a rapidly growing pharmaceutical company that manufactures and markets both prescription and consumer products.  Privately held since 1919, the company strives to recognize the unmet healthcare needs of its customers.  Upsher-Smith prides itself on providing safe, effective, and economical therapies to the ever-challenged healthcare environment.  For additional information about PreNexa®, visit www.prenexa.com, or to learn more about Upsher-Smith, visit www.upsher-smith.com.

References

(1) PreNexa (package insert).  Minneapolis, MN: Upsher-Smith Laboratories, Inc; 2010.

(2) Medline Plus.  http://www.nlm.nih.gov/medlineplus/druginfo/natural/patientfishoil.html.  Accessed September 9, 2008.

(3) Koletzko, et al.  The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy; review of current knowledge and consensus recommendations.  J Perinat Med 36 (2008)5-14.

(4) Mulligan ML, Felton SK, Riek AE, et al. Implications of vitamin D deficiency in pregnancy and lactation. Am J Obstet Gynecol 2009;201.

SOURCE Upsher-Smith Laboratories, Inc.